3 Biotech Stocks to Buy in July
It's been a rough year to be a biotech investor. The market-cap-weighted iShares Nasdaq Biotechnology ETF is down about 25% so far this year.
from Biotech News
It's been a rough year to be a biotech investor. The market-cap-weighted iShares Nasdaq Biotechnology ETF is down about 25% so far this year.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments